How to Choose a CBD Brand: A 7-Point Checklist for 2026

Last updated: May 12, 2026 · By Arkos Bioscience Science Team

TL;DR, The 7-point checklist

Step 1

Does the brand publish batch-level COAs from an ISO 17025-accredited lab?

A Certificate of Analysis (COA) is the foundational document of any credible CBD product. It is the proof that an independent laboratory, not the brand itself, has tested the product and confirmed what is (and is not) in it. Without a publicly accessible, current COA, every other claim the brand makes is unverifiable.

Not all COAs are equal. A potency-only COA confirms CBD content but says nothing about whether the product contains lead, arsenic, pesticide residues, or residual extraction solvents. A full-panel COA covers:

• Cannabinoid potency, exact mg/ml or % of CBD, THC, and other cannabinoids
• Heavy metals, lead, mercury, arsenic, cadmium
• Pesticide residues, particularly relevant for non-organic hemp
• Residual solvents, ethanol, butane, propane, and other extraction-process residues
• Microbial contamination, total yeast, mold, and bacterial counts

The testing laboratory must be ISO 17025-accredited, the international standard for calibration and testing laboratory competence. This accreditation ensures the lab's methods, equipment, and personnel meet a documented quality management system. A COA from a non-accredited lab is not meaningless, but it carries significantly less evidentiary weight.

The COA should be batch-specific: the lot number printed on the product should correspond directly to a COA document you can access. Brands that provide a generic "representative sample" COA without batch-level specificity cannot confirm that the bottle you hold matches the tested product.

Step 2

Where is the hemp sourced from?

Hemp (Cannabis sativa L.) is a bioaccumulator, the plant draws minerals, heavy metals, and other compounds from soil into its biomass. This property is beneficial in phytoremediation contexts but creates a direct contamination risk when the input soil contains pesticide residues, industrial pollutants, or heavy metals.

US-grown hemp is regulated at the federal level by the USDA Farm Bill program and at the state level by individual Department of Agriculture licensing and inspection programs. These frameworks establish minimum standards for licensed growers, including soil testing requirements in many states. This does not guarantee safety on its own, but it creates a regulatory accountability structure that is absent in many foreign hemp supply chains.

USDA Certified Organic hemp carries the additional requirement that the growing operation was inspected by an accredited certifying agent and meets organic system plan requirements covering pesticides, fertilizers, and land use history. For users who prioritize clean inputs, organic-certified US hemp represents the current gold standard in commercially available CBD sourcing.

When evaluating a brand's hemp source: look for the state of origin (Colorado, Kentucky, Oregon, and North Carolina have established hemp programs), ask whether the farm is certified organic, and confirm the COA pesticide panel is clean, regardless of organic certification status.

Step 3

What extraction method is used?

The extraction method determines both the chemical profile of the final CBD extract and the potential for residual contaminants. The two methods that have the strongest safety record and widest regulatory acceptance for food-grade and supplement-grade cannabinoid products are supercritical CO2 extraction and high-purity ethanol extraction.

Supercritical CO2 extraction uses carbon dioxide under controlled temperature and pressure to selectively extract cannabinoids and terpenes from hemp biomass. It leaves no solvent residue, produces a clean extract, and the process parameters can be tuned to target specific cannabinoid fractions. CO2 extraction equipment is capital-intensive, which is part of why it correlates with higher-quality production operations.

Ethanol extraction uses high-purity food-grade ethanol as a solvent. It is efficient, scalable, and, when properly executed with appropriate winterization and residual solvent purging, produces a high-purity extract. The COA residual solvent panel should confirm ethanol levels are below established safety thresholds.

Methods to be cautious about include hydrocarbon extraction (butane, propane) without verified residual solvent data, and unspecified "proprietary extraction processes" that prevent independent evaluation. If a brand cannot tell you how they extract their CBD, they cannot meaningfully stand behind the purity of the product.

After extraction, some brands perform additional refinement steps (winterization, distillation, chromatography) to increase CBD concentration and remove waxes, lipids, and chlorophyll. The level of refinement is reflected in whether the final product is a full-spectrum extract, broad-spectrum, or isolate, each with distinct chemical profiles.

Step 4

Is the exact CBD milligram-per-serving clearly listed?

Consistent, accurate dosing requires knowing precisely how much CBD is in each serving. This sounds elementary, but a significant portion of CBD products in the market either omit this information, present it ambiguously, or label it inaccurately relative to the actual measured content on the COA.

The label should state something specific and verifiable: "20mg CBD per serving (1ml)" or "600mg CBD per 30ml bottle (20mg/serving)." Terms like "hemp extract 500mg" or "full-spectrum phytocannabinoid-rich hemp oil" without an explicit CBD milligram figure leave the actual CBD dose unknown, and potentially undeclared because it is negligible.

Cross-reference the labeled amount against the COA potency panel. Independent testing organizations (ConsumerLab publishes CBD product reviews) have documented systematic label inaccuracy in the CBD category, with some products delivering significantly less CBD than labeled. Brands that have had their products independently verified by ConsumerLab or similar organizations provide an additional layer of confirmation beyond their own COA.

For nano-encapsulated or water-soluble products specifically, the CBD concentration per serving is the baseline you need to compare absorption efficiency meaningfully. A 10mg dose from a 3-8x more bioavailable formulation delivers a different effective exposure than 10mg from a standard oil, but only if the 10mg figure is accurate to begin with.

Step 5

What is the THC content, and is it labeled accurately?

Federal law in the United States permits hemp-derived CBD products to contain up to 0.3% delta-9 THC by dry weight. This threshold means that products at the legal limit are not THC-free in any pharmacologically or forensically meaningful sense, they simply meet the agricultural classification requirement for hemp.

For users with drug screening obligations, employment policies, professional licensing requirements, or personal preferences to avoid THC entirely, the relevant benchmark is 0.0% or ND (not detected) on the COA. This requires a THC-free formulation using CBD isolate or a broad-spectrum extract with verified THC removal, not simply a full-spectrum extract that happens to fall under the 0.3% threshold.

The COA should specify the testing method and detection limits. A result of "ND" is only meaningful if the detection limit is stated (typically <0.01% or <0.001%), a non-detect at an unspecified detection threshold provides no useful information.

It is also worth noting that THC isomers (delta-8, delta-10, THC-O) are not always included in standard COA panels. If a brand's products contain these compounds, sometimes added to broad-spectrum formulations, they should be explicitly disclosed and included in the testing panel. Brands that make "THC-free" claims without a comprehensive cannabinoid panel covering minor THC variants warrant closer examination.

Step 6

Is there a named scientist or formulator on the team?

The CBD supplement space has a well-documented marketing credibility problem: brands routinely make specific claims about bioavailability, onset speed, absorption enhancement, and physiological effects that exceed what existing published research supports. One meaningful accountability signal, imperfect but useful, is whether a named, credentialed scientist or licensed pharmacist is publicly associated with the formula.

What to look for: a named PhD, PharmD, MD, or equivalent professional with a verifiable publication record, institutional affiliation, or professional licensing profile. Not a "Chief Wellness Officer" with an unspecified background. Not a brand ambassador. The scientist should have a demonstrable connection to the relevant disciplines, pharmacology, biochemistry, pharmaceutical sciences, or related fields, and the connection should be current, not historical.

A verifiable LinkedIn profile that matches the credentials claimed on the brand's website provides basic confirmation. Academic publications in relevant peer-reviewed journals are stronger. A brand founded by a researcher with a traceable publication or patent history in the underlying technology (nano-encapsulation, drug delivery, cannabinoid pharmacology) is the most credible scenario.

This does not guarantee product quality, scientists can make poor formulation decisions, and credentialed teams can still produce substandard products. But it establishes a traceable point of accountability for the technical claims. If the product's claimed absorption advantages cannot be defended by anyone who understands the underlying science, the claims should be treated skeptically.

Step 7

Are reviews verified and recent?

Consumer reviews are an imperfect but useful data source for CBD products, where individual product quality can vary between batches and where user experience (onset, effect duration, taste, consistency) is difficult to assess from a COA alone. The key is distinguishing verified-purchase reviews from unverified testimonials, and recent reviews from legacy ratings accumulated under earlier formulations.

Prioritize reviews from independent platforms, Trustpilot, Google Business Profile, and the Better Business Bureau, over reviews published exclusively on a brand's own website. Brands control their own website testimonials; they have limited control over third-party review platforms.

Signals of a credible review profile: a substantial volume of reviews (100+) spread over at least 12 months, a pattern of the brand responding to both positive and negative reviews, and a distribution that shows some 3-star and below responses (perfectly uniform 5-star reviews are a known signal of manipulation). Review recency matters because product formulations, supply chains, and quality control can change, a strong record from three years ago does not guarantee current consistency.

Some independent organizations also review CBD brands systematically. ConsumerLab, for example, conducts blind third-party testing of commercially purchased CBD products and publishes comparative potency accuracy and contamination data. A brand that has been positively reviewed by ConsumerLab has passed an independent purchase-and-test evaluation that carries more evidentiary weight than any number of customer testimonials.

Red flags table, what to avoid

The following signals indicate a brand may not meet minimum transparency and quality standards. None are automatically disqualifying in isolation, but patterns of multiple red flags warrant strong caution.

How Arkos Bioscience meets each criterion

We apply the same checklist to ourselves. Here is where Arkos Bioscience stands on each point as of May 2026:

Frequently asked questions

Sources

• National Center for Biotechnology Information (PMC), Cannabidiol pharmacokinetics, oral bioavailability (~6% for standard oral administration), and absorption factors
• Frontiers in Nutrition, Oral CBD bioavailability and nanoformulation delivery research
• Molecules (MDPI), Nano-encapsulation delivery systems for cannabinoids; particle size and absorption enhancement data
• European Journal of Pharmaceutics and Biopharmaceutics, Drug bioavailability enhancement via nanoformulations and encapsulated delivery systems